Abiopharma

(81% Neutral) EPAM Systems Inc. (EPAM) Files Form 8-K

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ais Drug Discovery Platform Matters More Than Ever

(99% Neutral) Acadia Pharmaceuticals (ACAD) Reports Q1 2026 Financial Results

📋 Chopas James George (Officer) plans to sell 873 shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $19K) Filed: Jan 13, 2026 | ID: 000284

📋 Watson David O. (Officer) plans to sell 6K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $128K) Filed: Jan 13, 2026 | ID: 000283

📋 DeLong Mark Jeffrey (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $39K) Filed: Jan 13, 2026 | ID: 000282

📋 Deschatelets Pascal (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $51K) Filed: Jan 13, 2026 | ID: 000281

Notification from BriaCell Therapeutics Corp.

📋 Francois Cedric (Officer) plans to sell 10K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $226K) Filed: Jan 13, 2026 | ID: 000280

📋 Sullivan Timothy Eugene (Officer) plans to sell 4K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $86K) Filed: Jan 13, 2026 | ID: 000278

New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000279 Size: 16 KB

New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000278 Size: 21 KB

Lexaria Bioscience Corp. (LEXX) Files Form 10-Q

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Director MATLIN DAVID J 🟢 acquired 33.3K shares (2 derivative) of Clene Inc. (CLNN) at $6.50 Transaction Date: Jan 13, 2026 | Filing ID: 001170